Search
Transcode Therapeutics Inc
RNAZAdd to Watchlist
1.770USD
+0.010+0.57%
Close 09-22 16:00（ET）
1.88MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+0.57%
5 Days
+10.63%
1 Month
-38.33%
6 Months
-80.29%
Year to Date
-74.08%
1 Year
-84.44%
Key Figures
1.870Open
1.911High
2.64KVolume
LossP/E TTM
0.00P/E Dynamic
--Dividend TTM
0.26%Turnover Ratio
1.760Prev. Close
1.707Low
4.77KTurnover
LossP/E Static
-0.06P/B
0.00%Div Yield TTM
-47.38%ROA
20.99052wk High
0.09Volume Ratio
-16.82MNet Profit
1.06MShares
-3.7086EPS TTM
1.32Beta
-757.04%ROE
1.57952wk Low
7.96%Amplitude
--Gross Margin
1.88MMarket Cap
-10.08Reward/Risk
6.31%Risk Rate
More news coming soon, stay tuned...
Transcode Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-7.17/--
Revenue / Forecast
--/--
Transcode Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolRNAZ
Number of employees7
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| CK Life Sciences International Holdings, Inc. | 9.08% |
| Sabby Management, LLC | 4.54% |
| Geode Capital Management, L.L.C. | 1.20% |
| UBS Financial Services, Inc. | 0.90% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 9.08% |
| Investment Advisor/Hedge Fund | 5.73% |
| Investment Advisor | 2.66% |
| Individual Investor | 0.14% |
Related Instruments
+0.45%
-0.10%
+0.28%
+0.94%
+0.21%
+0.16%
+4.34%
+1.40%
-1.01%
+0.68%
+0.84%
-0.59%
+0.54%
+0.02%
-0.70%
+0.72%
+5.56%
+0.32%
-2.47%
-1.64%
FAQs
What is the current price of Transcode Therapeutics Inc (RNAZ)?
The current price of Transcode Therapeutics Inc (RNAZ) is 1.77.
What is the symbol of Transcode Therapeutics Inc?
The ticker symbol of Transcode Therapeutics Inc is RNAZ.
What is the 52-week high of Transcode Therapeutics Inc?
The 52-week high of Transcode Therapeutics Inc is 20.99.
What is the 52-week low of Transcode Therapeutics Inc?
The 52-week low of Transcode Therapeutics Inc is 1.58.
What is the market capitalization of Transcode Therapeutics Inc?
The market capitalization of Transcode Therapeutics Inc is 1.77M.
What is the Earnings Per Share (EPS TTM) of Transcode Therapeutics Inc (RNAZ)?
The Earnings Per Share (EPS TTM) of Transcode Therapeutics Inc (RNAZ) is -3.71.